The chemical class of RYBP Activators comprises a diverse array of compounds, each interacting with cellular pathways in unique ways that can indirectly influence the activity of RYBP (Ring1 and YY1 binding protein). These chemicals, although not direct activators of RYBP, operate through various mechanisms that intersect with the biological functions of RYBP, especially in the context of gene regulation, chromatin architecture, and cellular stress responses. The first group within this class includes histone deacetylase (HDAC) inhibitors like Vorinostat and Valproic Acid. By altering chromatin structure and histone acetylation, these inhibitors can potentially modulate RYBP's role in transcriptional regulation. Genistein, a tyrosine kinase inhibitor, and PIK-75, a PI3K inhibitor, represent another category that affects key signaling pathways, possibly intersecting with those regulated by RYBP. Proteasome inhibitor MG132 and AMPK activator AICAR (Acadesine) influence protein dynamics and metabolic pathways, respectively, creating conditions that could modulate RYBP's functional dynamics.
Moreover, compounds like JQ1, a BET bromodomain inhibitor, and U0126, an MEK inhibitor, highlight the class's diversity by targeting chromatin interactions and MAPK/ERK signaling pathways. The MDM2 inhibitor Nutlin-3 and Aurora kinase inhibitor ZM447439 emphasize the class's role in influencing cell cycle regulation pathways, where RYBP could be implicated. Additionally, SB431542, a TGF-beta receptor inhibitor, and SP600125, a JNK inhibitor, demonstrate the potential impact of these activators on differentiation, proliferation, and stress response pathways, potentially intersecting with RYBP's functional spectrum.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor with known effects on various cellular signaling pathways. By inhibiting tyrosine kinases, it might alter signaling cascades that could intersect with those regulated or influenced by RYBP, potentially altering RYBP's role in gene regulation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an activator of AMP-activated protein kinase (AMPK). By activating AMPK, AICAR can influence metabolic pathways, potentially creating a cellular environment that intersects with RYBP's regulatory roles, especially in energy metabolism and stress responses. | ||||||
PIK-75, hydrochloride | 372196-77-5 | sc-296089 sc-296089A | 1 mg 5 mg | $29.00 $124.00 | ||
PIK-75 is a PI3K inhibitor. By modulating PI3K signaling pathways, it could indirectly influence pathways in which RYBP is involved, particularly those related to cell growth, survival, and metabolism. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor. It inhibits the recognition of acetylated histones, potentially affecting chromatin interactions and transcriptional regulation. This might influence pathways where RYBP is involved, given RYBP's role in chromatin modification and gene regulation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 is a MDM2 inhibitor. It stabilizes p53 by preventing its interaction with MDM2. This stabilization of p53 can influence cell cycle and apoptosis pathways, potentially intersecting with pathways involving RYBP. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439 is an Aurora kinase inhibitor. By inhibiting Aurora kinases, it can influence cell cycle regulation pathways, where RYBP might be involved, particularly in the context of chromatin modification and mitotic progression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-beta receptor. By inhibiting this pathway, it can impact cellular processes like differentiation and proliferation, potentially affecting signaling pathways intersecting with RYBP's role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. It modulates the stress response and inflammatory pathways by inhibiting JNK. This could influence cellular contexts and signaling pathways, potentially impacting RYBP, especially in stress response and inflammation. | ||||||